Author： Mabuchi Hiroshi Inazu Akihiro
Publisher： Future Medicine
ISSN： 1746-0875
Source： Future Lipidology, Vol.1, Iss.4, 2006-08, pp. : 487-500
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Epidemiological studies have shown that low-density lipoprotein cholesterol (LDL-C) is a strong risk factor for coronary heart disease (CHD), whilst high-density lipoprotein cholesterol (HDL-C) reduces the risk for CHD. Therefore, strategies to manage dyslipidemia in an effort to prevent or treat CHD have primarily attempted to decrease LDL-C and raise HDL-C levels. Cholesteryl ester transfer protein (CETP) inhibitors have proven to be effective in achieving both a reduction in LDL-C and an increase in HDL-C. This review will discuss the current status and future prospects of CETP inhibitors in the treatment of CHD.
Related content
By Dullaart R P F Beusekamp B J Riemens S C Hoogenberg K Stulp B K van Tol A Sluiter W J
Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 58, Iss. 3, 1998-07 ,pp. :
Access to resources
Recommend
By Park Jungho Kim Jae-Ryong Shin Dong-Gu Cho Kyung-Hyun
International Journal of Molecular Medicine, Vol. 29, Iss. 4, 2012-04 ,pp. :
By Riemens S. C. Van Tol A. Scheek L. M. Dullaart R. P . F.
Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 1, 2001-02 ,pp. :
Significance of High‐Density Lipoprotein Cholesterol*
JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 26, Iss. 10, 1978-10 ,pp. :